Shaping the Future of Biotech Trials: An Interview with John Moller, CEO of Novotech
Frost & Sullivan
MAY 12, 2025
John Moller : We aim to be the global CRO (Contract Research Organization) of choice for biotech and small to mid-size pharma. Trusted Partner, Not Just a Vendor Unmesh Lal: Whats your approach to client experience? He originally joined as COO for Asia in 2014, driving regional growth and delivery capabilities.
Let's personalize your content